Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,032,933
-$6,489,776 QoQ
Shares Held
2,097,202
+14.3% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 20.98848847178288.ToString("F0")%
Shared 0.ToString("F0")%
None 79.01151152821711.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. EYPT ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in EYPT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,032,933 | 2,097,202 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,522,709 | 1,834,850 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $20,978,353 | 1,473,199 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,261,316 | 1,515,549 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,635,203 | 1,593,211 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,112,919 | 1,491,667 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,714,889 | 1,215,881 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,611,642 | 1,219,729 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $21,343,263 | 1,032,572 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,724,573 | 550,609 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,259,109 | 533,055 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,382,016 | 503,680 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,323,661 | 450,225 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,574,146 | 449,756 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,430,820 | 433,732 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,179,952 | 404,060 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,561,960 | 375,470 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,374,098 | 357,361 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,153,394 | 302,629 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,037,574 | 226,649 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||